Oxidative stress in patients with benign prostate hyperplasia

Journal of the Nepal Medical Association

Volumn 46, Issue 167, 2007, Pages 103-106

  Aryal, Madhukar ^a   Pandeya, A ^a   Das, B K ^a   Lamsal, M ^a   Majhi, S ^a   Pandit, R ^a   Agrawal, C S ^a   Gautam, N ^b   Baral, N ^a  

^a B P KOIRALA INSTITUTE OF HEALTH SCIENCES   (Nepal)

^b Universal College of Medical Sciences   (Nepal)

Author keywords

Benign prostate hyperplasia; Malondialdenyde; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CATALASE; FREE RADICAL; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

AGING; ARTICLE; BLOOD CHEMISTRY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HUMAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PROSTATE HYPERTROPHY; VITAMIN BLOOD LEVEL;

AGED; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PROSTATIC HYPERPLASIA;

EID: 42249101593     PISSN: 00282715     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Mac Connell JD, George FW, Wilson JD, Geller J, Stoner E. The effect of low dose finasteride (MK-906) on the prostate androgen level in men with benign hyperplasia. J Urol 1990; 17: 661-7.
2. Levine AC. Pathogenesis and medical management of Benign Prostate Hyperplasia. Trends Endocrinol Metab 1995; 6: 128-32.
3. Ohkawa H, Ohishi N, Yagi K. Assay for peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351.
4. Ripple MO, Henry WF, Rago PR, Wilding G. Pro-oxidant-antioxidant shift induced by androgen treatment by androgen treatment of human prostate carcinoma cells. J Natl Cancer Inst 1997; 89: 40-8.
5. Meagherra EA, Fitzgerald GA. Indices of lipid peroxidation in vivo: Strength and Limitation. Free radic Biol Med 2000; 28: 1745-50.
6. Yagi K. Lipid peroxide and human disease. Chem Phy Lipids 1987; 45: 337-51.
7. Biere JG, Teets L, Belavculy B, Andrews EC. Serum Vit E level in normal adult population in Washington DC area. Proc Soc Exptl Biol Med 1964; 117: 131-33.
8. Sullivan MX, Clark HCN. A colorimetric method for determination of ascorbic acid. J Assoc offic Agric Chem 1955; 38: 514.
9. Meredino RA, Salvo F, Antenella S, Pasquala GD, Tomaino A, Minicuillo PL, Fraccica G, Gangemi S. Malondialdehyde in Benign Prostate Hypertrophy: a useful marker. Mediators Inflamm 2003; 12: 127-8.
10. Barker AM, Oberley LW, Cohen MB. Expression of antioxidant enzymes in human prostate adenocarcinoma. Prostate 1997; 32: 229-33.
11. Winkler BS, Orselli SM, Rex TS. The redox couple between glutathione and ascorbic acid a chemical and physiological perspective. Free Radic Biol Med 1994; 17: 333-49.
12. Buttke TM, Sandstrom PA, Oxidative stress as a mediator of apoptosis. Immunol Today 1994; 15: 7-10.
13. Cooke MS, Evans MD, Herber KE, Lunee J. Urinary 8 - Oxo-2′ deoxyguanosine source, and supplements. Free Radical Res 2000; 32: 381-97.
14. Sikka SC. Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention -a mechanistic approach. Curr Med Chem 2003; 10: 2679-92.